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Burn injuries are one of the most common types of trauma worldwide, and their unique physiology
requires the development of specialized therapeutic materials for their treatment. Here, we report the
use of synthetic, functional and biodegradable peptide nanofiber gels for the improved healing of burn
wounds to alleviate the progressive loss of tissue function at the post-burn wound site. These bioactive
nanofiber gels form scaffolds that recapitulate the structure and function of the native extracellular
matrix through signaling peptide epitopes, which can trigger angiogenesis through their affinity to basic
growth factors. In this study, the angiogenesis-promoting properties of the bioactive scaffolds were
utilized for the treatment of a thermal burn model. Following the excision of necrotic tissue, bioactive
gels and control solutions were applied topically onto the wound area. The wound healing process was
evaluated at 7, 14 and 21 days following injury through histological observations, immunostaining and
marker RNA/protein analysis. Bioactive peptide nanofiber-treated burn wounds formed well-organized
and collagen-rich granulation tissue layers, produced a greater density of newly formed blood vessels,
and exhibited increased re-epithelialization and skin appendage development with minimal crust for-
mation, while non-bioactive peptide nanofibers and the commercial wound dressing 3M™ Tegaderm™
did not exhibit significant efficiency over sucrose controls. Overall, the heparin-mimetic peptide nano-
fiber gels increased the rate of repair of burn injuries and can be used as an effective means of facilitating
wound healing.
© 2017 Elsevier Ltd. All rights reserved.1. Introduction
Burn injuries are the fourth most common type of trauma
worldwide, and third-degree burns constitute one of the most se-
vere injuries of the skin. Although recent developments in post-
injury care have greatly improved the survival and recovery rates
of patients suffering from severe burns, the considerable length ofcience and Nanotechnology,
echnology Research Center
gineering, University of Chi-
ler), atekinay@bilkent.edu.trthe recovery process and the concurrent risk of infection contribute
to patient mortality in burn injuries [23]. Even under ideal condi-
tions, the formation of scar tissue follows wound closure, and may
compromise the appearance and functionality of the healed tissue
[12]. In addition, burn wounds are subject to a higher risk of ne-
crosis compared to lacerations and blunt trauma injuries due to the
oxidative and inflammatory stresses exerted by the zone of coag-
ulation [25,30]. Consequently, untreated burn injuries often expe-
rience a period of progression where viable tissues adjacent to
necrotic regions are themselves converted into necrotic tissue,
increasing the depth and diameter of the injury [26,31]. Severe
burn injuries are also associated with a rapid and systemic immune
response that may result in septic shock due to a combination of
increased capillary permeability, an excess of proteins in the
interstitial space, and the overexpression of pro-inflammatory
F. Yergoz et al. / Biomaterials 134 (2017) 117e127118factors by macrophages [6]. Taken together, these factors necessi-
tate the development of novel techniques that specifically address
the unique pathophysiological needs of burn injuries, especially in
the context of halting burn wound progression and facilitating
tissue repair with minimal scar formation [29].
Hydrogels are effective materials for the treatment of burn in-
juries due to their water-retaining properties, which allow them to
modulate the fluid balance at the site of injury and provide an
environment similar to that present in native skin tissue. They can
be functionalized with bioactive or antimicrobial agents to prevent
secondary infections or accelerate the wound repair process [12].
Self-assembled peptide nanofiber gels contain bioactive sequences
that effectively replicate the functions of many extracellular matrix
proteins, allowing their use for the repair of a broad range of tissue
injuries [10,22,24]. However, the function of peptide nanofiber
systems depends strongly on their sequence, with minimal alter-
ations resulting in major changes in toxicity, bioactivity and as-
sembly kinetics [17,37]. Previously, peptide gels bearing the RGD-
like RADA16 and ILVAGK/LIVAGK sequences were used as wound
dressings for burn and laceration injuries [11,15], and we recently
reported that heparin-mimetic peptide nanofibers (HM-PA, lauryl-
VVAGEGD(K-psb)S-Am) increase re-epithelialization and granula-
tion tissue formation in a rat acute skin wound model [35]. In
contrast, a non-bioactive control gel (bearing a similar secondary
structure but no heparin-mimetic motifs) provided no improve-
ment over sucrose-treated controls, suggesting that the sequence
(rather than the presence of the gel as a scaffold) was effective in
promoting wound healing. HM-PA was shown to stimulate angio-
genesis in vivo and exhibit a strong affinity to the growth factors
VEGF, HGF, and FGF-2 in vitro, which is related to its ability to
enhance wound repair [13]. However, post-injury progression of
tissue necrosis, local accumulation of inflammatory cytokines,
rapid fluid loss from blood vessels at the site of injury and an
extended period of inflammation complicate the recovery of burn
injuries, limiting the applicability of wound healing scaffolds in
their treatment [34]. Consequently, it is interesting to use same
peptide system for promotion of wound recovery under the unique
microenvironmental conditions associated with burn wounds.
In the present study, we show that HM-PA nanofiber gels
facilitate the recovery of burn injuries caused by a thermal burn
model developed for the evaluation of topical treatment methods.
Wound regeneration was monitored through histological obser-
vations, immunostaining and marker protein expressions across 21
days of recovery, and blood vessel densities, collagen organization
and skin appendage formation were quantified to determine the
effect of bioactive PA treatment on the repair process. HM-PA
treatment was observed to enhance angiogenic activity during
early regeneration; increase wound closure, re-epithelialization
and granulation tissue formation rates, and promote the forma-
tion of skin appendages compared to non-bioactive peptide nano-
fibers, sucrose and 3M™ Tegaderm™ wound filler, suggesting that
the HM-PA gel can be utilized as a potential platform for the
treatment of burn wounds in addition to laceration injuries.
2. Materials and methods
2.1. Materials
9-Fluorenylmethoxycarbonyl (Fmoc) and tert-butoxycarbonyl
(Boc) protected amino acids, lauric acid, 4-(20,40-dimethox-
ymethyl-Fmoc-aminomethyl)-phenoxyacetamido-norleucyl-
MBHA resin (Rink amide MBHA resin), Fmoc-Asp(OtBu)-Wang
resin, 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetramethyluronium hexa-
fluorophosphate (HBTU) and diisopropylethylamine (DIEA) were
purchased from NovaBiochem (Merck) and all other chemicals arepurchased from Sigma-Aldrich, Thermo scientific, Invitrogen and
Fisher. Antibodies used in this studywere purchased fromMillipore
and Abcam.
2.2. Synthesis and purification of molecules and gel formation
An Fmoc solid phase peptide synthesis method was followed for
the synthesis of peptide amphiphile (PA) molecules. Two different
solid supports were used for peptide synthesis: The positively-
charged K-PA (lauryl-VVAGK-Am) and negatively-charged HM-PA
(Lauryl-VVAGEGD(K-psb)S-Am) were fabricated using Rink amide
MBHA resin, while the other negatively-charged PA (E-PA (lauryl-
VVAGE)) was synthesized on Fmoc-Glu(OtBu)-Wang resin. Syn-
thesis protocols were identical to these provided by Uzunalli et al.
[35]. The mass and purity of molecules were assessed with liquid
chromatographyemass spectroscopy (LCeMS). LC-MS data were
obtained with an Agilent LC-MS equipped with Agilent 6530 Q-TOF
with ESI source and Zorbax SB-C8 4.6 mm  100 mm column for
acidic conditions and a Zorbax Extend-C18 2.1 50 mm column for
basic conditions. Mobile phases of each column were a gradient of
water and acetonitrile containing 0.1% formic acid (for basic pep-
tides) or 0.1% NH4OH (for acidic peptides). Residual TFA adhering to
positively charged PAs was removed by treatment with HCl solu-
tion, and the remaining peptide residuewas lyophilized. An Agilent
1200 series preparative reverse-phase high performance liquid
chromatography (HPLC) system was used for the purification of
molecules and was equipped with a Zorbax Extend-C18
21.2  150 mm column for basic conditions and a Zorbax SB-C8
21.2  150 mm column for acidic conditions. As the mobile pha-
ses of each column, a gradient of water and acetonitrile containing
0.1% TFA or 0.1% NH4OHwas used according to charge of conditions.
In order to enable nanofibrous gel formation through charge
neutralization, each oppositely-charged PA was reconstituted in
0.25 M sucrose solution prepared in ultrapure water and mixed at
themolar ratio of 1:2 for the HM-PA/K-PA combination (resulting in
a bioactive PA mixture) and 1:1 M ratio for the E-PA/K-PA (resulting
in a non-bioactive control PA mixture). Total charges of both mix-
tures were 1. The pH of peptide solutions was adjusted to 7.4 and
peptide mixtures were sterilized with UV light for 1 h prior to use.
2.3. Physical and mechanical characterization of self-assembled
peptide nanofiber networks
2.3.1. Scanning electron microscopy (SEM)
Nanofiber networks formed by HM-PA/K-PA (1:2 M ratio) and E-
PA/K-PA (1:1 M ratio) were inspected through SEM. Samples for
SEM were prepared by incubating peptide nanofiber gels (1 wt %)
with a final volume 60 mL for 20 min on silicon wafers. The peptide
nanofiber gels were then dehydrated by sequential treatment with
increasing concentrations of ethanol (20%, 40%, 60%, 80% v/v) for
2 min per wash and left in 100% absolute ethanol until drying in a
critical point drier (Tousimis, Autosamdri-815B). Before the imag-
ing process, samples were coated with 6 nm of Au/Pd layer and
images were taken with a FEI Quanta 200 FEG scanning electron
microscope under high vacuum with 5 kV beam energy.
2.3.2. Oscillatory rheology
An Anton Paar Physica RM301 rheometer operating with a
25 mm parallel plate at 21 C was used for oscillatory rheology
measurements. In order to measure storage (G0) and loss (G00)
moduli, HM-PA or control nanofiber gels (1 wt %) with total volume
of 300 mL were loaded on the center of the lower plate and incu-
bated for 15 min prior to measurement while upper plate was
brought to a 0.5 mm gap position. While taking storage moduli (G0)
and loss moduli (G00) measurements, angular frequency was
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was repeated 3 times for each peptide nanofiber gel and consecu-
tive measurements were averaged for each sample.
2.3.3. Circular dichroism (CD)
Secondary structures of HM-PA nanofiber or control nanofiber
assemblies were examined by CD spectroscopy using a J-815 Jasco
J815 CD spectrophotometer at room temperature. Initially, PA stock
solutions were prepared at 1 mM concentration and diluted to a
concentration of 3.6  104 M for CD spectroscopy. Measurements
were obtained 3 times in the range of 300 nme190 nm with
100 nm/min scanning speed, 1 nm bandwidth and 0.1 nm data
pitch and 0.1 nm data interval, with digital integration time (1 DIT)
as 1 s at standard sensitivity. Three consecutive measurements
were averaged for each sample. The results were modified and
shown as molar ellipticity.
2.4. In vivo burn model
All procedures performed in the present study were approved
by The Animal Experiments Ethical Committee of Gazi University.
In vivo experiments were carried out with 3e4 month old
(20e30 g) male BALB/c mice. Full-thickness dorsal burn wounds
were created following a protocol modified from Sun et al. (Fig. 1)
[32]. A total of 60 male mice were randomly divided into 4
groups for HM-PA nanofiber treatment (n ¼ 15), control nano-
fiber treatment (n ¼ 15), sucrose solution treatment (n ¼ 15) and
3M™ Tegaderm™ hydrogel treatment (n ¼ 15). Mice were
maintained on ad libitum access to a standard laboratory diet in a
12-12 h light-dark cycle. Mice were anesthetized byFig. 1. Schematic representation of the full-thickness burn wound model. (a) A pre-heated al
by the removal of the injured skin and the application of the hydrogel. (b) A schematic of th
prepared using Mind the Graph software.intraperitoneal injection of ketamine hydrochloride (45 mg/kg)
and xylazine hydrochloride (5 mg/kg). Under deep anesthesia,
long hairs found on their dorsa were removed with a clipper and
then shaved by a razor blade for complete hair removal. After the
sterilization of underlying skin with povidone iodide, 3rd degree
burns were generated with a custom made 200 g aluminum rod
heated to 100 C in a boiling water bath for 10 min. The tip of the
aluminum rod was used as a template to generate 1 cm2 wounds
with square shapes on the posterior-dorsum of each mouse for
6 s. Within 30 min of burning, mice were resuscitated through
intraperitoneal injection of saline using half-strength Parkland
formula (4 mL/kg x percent body area). After 48 h, full thickness
skin layers were removed from the wounds using a biopsy punch
to generate 6 mm-diameter wounds. The debridement process
was performed to accurately reflect the current medical standard
for the treatment of burn injuries. The wounds were then treated
with bioactive or non-bioactive peptide solutions, 0.25 M sucrose
solution or 3M™ Tegaderm™ hydrogel. Lyophilized peptide
masses were dissolved in 0.25 M sucrose solution to preserve
osmotic balance. Gels were prepared by mixing oppositely
charged PA molecules at a final concentration of 1 wt % imme-
diately prior to application. 0.25 M sucrose solution was used as a
negative control, while 3M™ Tegaderm™ hydrogel was used as
positive control. Following the application of each treatment,
wounds were covered with gauze dressing and impregnated with
saline, and a long-term adhesive, air permeable, elastic and
sterile bandage (OctaCare®) was placed over the wound to sta-
bilize the position of treatments. Gels (and sucrose solution)
were re-applied and the wounds were re-dressed daily for two
days post-wounding. Mice were then individually caged anduminum plaque was applied to the shaved dorsum of the anesthetized mouse; followed
e hydrogel-implanted wound site. Schematic representations of the burn model were
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conducted throughout the study for infection and body weight
loss. Animals were sacrificed at each experimental end point (day
0, day 7, day 14, day 21) and their tissues were extracted to
continue with further analysis. Half of the tissue was used for
histological analysis and the other half was used for RNA and
protein analysis.
2.5. Wound area measurement
Wounds were photographed on days 7, 9, 12, 14, 16, 19 and 21
post wounding with a ruler. The scab areas on the top of the wound
were measured and calculated with Image J software (NIH, USA).
2.6. Histological analysis
Half of the skin tissues of sacrificed mice were collected at day
7, 14 and 21, and fixed in 10% formalin. Following the fixation of
extracts, samples were dehydrated in serially increasing con-
centrations of ethanol (70%e100%), embedded in paraffin and
5 mm skin sections were serially taken using a microtome. Tissue
sections were incubated at 58 C overnight and stained with
hematoxylin and eosin (H&E), Masson's trichrome and picrosir-
ius red with standard protocols after deparaffinization in xylene
and rehydration in gradually decreasing concentrations of
ethanol (%100-%70). All the quantifications from H&E and Mas-
sons' trichrome staining were performed using Image J. Images
from these stainings were acquired using an upright microscope
(Zeiss Axio Scope A1) at 5 and 10 magnifications, and then
merged to observe whole skin tissue. Firstly, whole granulation
area was traced and measured from wound edges and remaining
muscle tissue at both sites. Wound closure was measured at
three different layers and their average was taken to best
represent the extent of repair. The crust area was also traced and
measured as an indicator of tissue necrosis following injury. Re-
epithelization was quantified by measuring the remaining gap
between left and right wound edges. Newly formed skin ap-
pendages were counted in the burned area and their density was
calculated. Newly synthesized collagen was also quantified.
Orientation of collagen fibers was analyzed using the Image J
plug-in Orientation J. Scoring was also confirmed by researchers
who were blind to the study design.
2.7. Immunohistochemical staining
For immunohistological stainings, the tissue sections were
deparaffinized in xylene and rehydrated in graded ethanol solu-
tions and left in distilled water. Enzymatic antigen retrieval was
performed with 0.1% pronase for 10 min at 35 C or heat mediated
antigen retrieval was performedwith sodium citrate buffer (pH 6.0)
using the guidelines provided by Abcam. Endogenous peroxidase
activity was then inhibitedwith 3% hydrogen peroxide for 10min at
room temperature. Thereafter, normal goat serum was used to
block non-specific binding sites by treating slides for 2 h at room
temperature. Slides were incubated with anti-von Willebrand fac-
tor (1:400; ab6994, Abcam) overnight, followed by HRP conjugated
goat anti-rabbit secondary antibody (1:500, Millipore (12e349)) on
the next day. Antibody staining was followed by staining with 3,3’-
diaminobenzidine (DAB) and counterstaining with hematoxylin.
Mounting was performed with a xylene based mounting medium.
Digital images of the granulation area were acquired using an up-
right microscope (Zeiss Axio Scope A1) at 100 magnification
and merged to count newly formed blood vessels. Quantifications
were performed by ImageJ to calculate vessel density in each
granulation field.2.8. Protein and RNA isolation from tissue
The simultaneous isolation of RNA and protein from burn
wound samples was performed by using TRIzol reagent accord-
ing to the manufacturer's protocol with minor adaptations and is
briefly described below [3,7]. Firstly, tissue was weighed and cut
into small pieces with the help of a sterile surgical knife. Then,
tissue pieces were smashed with liquid nitrogen until they
became powder-like, and samples were homogenized with a
power homogenizer with 1 mL of TRIzol reagent per 50e100 mg
of tissue sample. The homogenate was incubated for 5 min to
permit the complete dissociation of the nucleo-protein complex,
mixed with chloroform (0.2 mL of chloroform per 1 mL of TRIzol
reagent used for initial homogenization) with vigorous shaking
and centrifuged, which yielded a colorless top aqueous phase, an
interphase, and an organic bottom phase. RNA was precipitated
from aqueous phase by addition of isopropanol (0.5 mL of 100%
isopropanol to aqueous phase per 1 mL of TRIzol reagent), mixed
15 times (up-down) and incubated at room temperature for
10 min. Then, the mixture was centrifuged to allow the formation
of a gel-like RNA pellet, washed with 2 mL of 75% ethanol, air-
dried for 5e10 min, dissolved in RNase-free water by pipetting
and stored at 20 C until use. DNA was precipitated from the
interphase and organic phase by the addition of ethanol (0.3 mL
of 100% ethanol per 1 mL TRIzol reagent used for initial ho-
mogenization) and centrifuged. Phenol-ethanol supernatant was
removed and saved for protein precipitation by the addition of
isopropanol (1.2 mL of isopropanol per 1 mL of TRIzol reagent
was used for initial homogenization). The protein-isopropanol
mixture was incubated overnight at 20 C to allow the pre-
cipitation of proteins and centrifuged to pellet them. The protein
pellet was washed with 2 mL of cold 0.3 M guanidine hydro-
chloride prepared in 95% ethanol 3 times with 20 min of incu-
bation between each washing, and then washed with ethanol at
the last washing step. The protein pellet was left to air-dry for
5e10 min, dissolved with 10 M urea containing a protease in-
hibitor cocktail (Sigma) [7] and stored at 20 C until use.
2.9. Quantitative reverse transcription polymerase chain reaction
(qRT-PCR)
The gene expression profiles of angiogenesis inducing growth
factors were evaluated by quantitative reverse transcription poly-
merase chain reaction (qRT-PCR) analysis. Yield and purity of
extracted RNA were assessed using the Nanodrop 2000 system
(Thermo Scientific). Primer sequences for growth factors were
selected according to their suitability by using PREMIER Bio-soft
software (Supplementary Table 1). Reaction efficiencies for each
primer set were evaluated with standard curves using at least 5-
fold serial dilutions of total RNA after the optimization of their
annealing temperatures. SuperScript III Platinum SYBR Green One-
Step qRT-PCR kit (Invitrogen) was used for cDNA synthesis and qRT-
PCR according to the manufacturers' instructions. Reaction condi-
tions were briefly as follows: 55 C for 5 min, 95 C for 5 min, 40
cycles of 95 C for 15 s, Tm (60 C, 60 C and 58 C for VEGF, bFGF,
GAPDH, respectively) for 30 s, and 40 C for 1 min, which was
followed by melting curve analysis to confirm product specificity
after each reaction. VEGF and bFGF gene expression profiles were
analyzed at days 7, 14, and 21. For the analysis of expression, pri-
mary gene expression data were normalized to the expression level
of GAPDH in each run, which served as the internal control gene.
Each group was then normalized to the expression levels of sucrose
solution treated groups, which served as a negative control. mRNA
levels were calculated according to the comparative Ct method
with efficiency correction for each target gene.
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After sacrificing the animals, half of the tissue samples collected
from animals were taken into microcentrifuge tubes and immedi-
ately frozen with liquid nitrogen to further characterize the
expression levels of proteins at days 7, 14 and 21 of the burnwound
healing process. Total protein in each sample was solubilized with
0.3 mL of 10 M urea and quantified with BCA assays (Thermo Sci-
entific) using a 1:50 dilution rate to eliminate the absorbance
coming from urea itself and to accurately quantify the protein stock
concentration. Equal amounts of proteins (70 ng, 20 mL) were
resolved on 10% SDS-PAGE under denaturing and reducing condi-
tions and transferred to polyvinylidene difluoride (PVDF) mem-
branes (Thermo Scientific). Membranes were blocked with 5% non-
fat milk in TBS-T for 1 h at room temperature and then incubated
with primary antibody at 4 C overnight. Anti-VEGF and anti-a-
SMA antibodies were purchased fromMillipore, ABS82, (1:750) and
04e1094, (1:1000), respectively. Anti-GAPDH antibody was used as
internal control and purchased from Millipore, MAB374 (1:500).
After washing in TBS-T, membranes were incubated with a corre-
sponding HRP-coupled secondary antibody for 1 h at room tem-
perature. Anti-rabbit IgG-HRP (purchased from Abcam) and anti-
mouse IgG-HRP (purchased from Millipore, 12e349) were used at
dilutions of 1:2000 and 1:1000, respectively. Signals were visual-
ized using enhanced chemiluminescence analysis on a ChemiDoc™
Imaging System with Image Lab™ Software (Bio-Rad). Protein
concentrations were quantified with ImageJ software and in-
tensities of VEGF and a-SMA were normalized to GAPDH.
2.11. Statistical analysis
Statistical analyses were performed by using GraphPad Prism 6
software. One way ANOVA with Tukey's post-tests or two way
ANOVA with Bonferroni post-tests was employed to determine the
statistical differences between groups, where appropriate. Error
bars indicate the standard error of the mean. The level of signifi-
cance was set at p < 0.05.
3. Results
3.1. Synthesis and characterization of PA molecules
Heparin-mimetic (HM-PA), negatively charged E-PA and posi-
tively charged K-PA molecules were synthesized by a solid phase
peptide synthesis method, purified by preparative HPLC, and their
molecular weights were confirmed byMS analysis prior to their use
(Fig. S1). The structure of the HM-PA molecule was designed to
mimic that of heparin through the presentation of sulfonate, hy-
droxyl and carboxylate groups, while E-PA was used as a non-
bioactive control peptide lacking reactive groups on its amino
acid side chains (Fig. 2a) [35]. When mixed with the positively-
charged K-PA at neutral pH, both peptide molecules self-
assembled into fibrous networks that closely resemble the struc-
ture of the extracellular matrix (Fig. 2d and e) and feature an
abundance of b-sheets, while individual PA molecules did not self-
assemble in the absence of a charge-neutralizing agent and
exhibited random coil structures (Fig. 2b). Storage and loss moduli
of both bioactive and non-bioactive peptide scaffolds were com-
parable to those of the commercial wound dressing 3M™ Tega-
derm™ (Fig. 2g). A representative image of PA nanofiber gels is
shown in Fig. 2f.
3.2. Gel treatment and dorsal burn injury model
Full-thickness burn wounds were visually monitored daily(Fig. 3a, detailed view presented in Fig. S5) and 5 animals from
each group were sacrificed for histological analysis at days 7, 14
and 21. Wound recovery was observed to be enhanced in
wounds treated with HM-PA peptide nanofibers, with signifi-
cantly smaller wound areas at days 12, 14, and 16 (Fig. 3b). In
contrast, neither the non-bioactive peptide mixture nor the
3M™ Tegaderm™ filling enhanced wound closure compared to
the negative control (0.25 mM sucrose) within the first 16 days
of recovery, although wound closure was complete in all
groups at day 21. In addition, HM-PA peptide nanofiber-treated
wounds exhibited a dense fur covering on top of the closed
wound (which was shaved prior to wound imaging), while 3M™
Tegaderm™- and sucrose-treated groups had limited fur growth
(Fig. 3a).3.3. Histological analysis
The effective recovery of burn wounds depends not only on
the closure of the wound itself, but also on the replacement of
damaged extracellular matrix with freshly deposited collagen,
the removal of local debris from the wound site and the forma-
tion of new skin appendages [16]. As such, skin sections taken at
7, 14 and 21 days following peptide nanofiber gel, 3M™ Tega-
derm™ or sucrose application were stained with H&E and Mas-
son's trichrome to observe the local morphology of the site of
injury (Fig. 4a). Granulation, re-epithelialization, crust formation,
wound contraction and skin appendage development were also
monitored to determine the extent of functional wound recov-
ery; representative images denoting the quantified regions are
provided in Fig. S7. The gradual decrease of granulation area is
one of the main hallmarks of skin wound recovery and
occurs through the contractile activity of myofibroblasts. HM-PA
peptide nanofiber gel treatment was found to result in signifi-
cantly smaller granulation tissue areas at day 7, suggesting
that the heparin-mimetic hydrogel enhanced fibroblast recruit-
ment and/or the differentiation of local fibroblasts into myofi-
broblasts (Fig. 4b). A similar trend was also observed in average
wound distance results, which also strongly depend on myofi-
broblast activity and suggest that wound contraction was
enhanced by bioactive peptide nanofiber gel treatment at day 7
(Fig. 4c).
In addition to the physical contraction of the site of injury,
wound recovery also depends on the local remodeling of the
extracellular matrix for the removal of local debris and deposi-
tion of new matrix proteins. While HM-PA peptide nanofiber
treatment had a significant impact on wound closure at the
earlier stages of the recovery process, its effects on matrix
remodeling were longer-lasting. In particular, bioactive peptide
nanofiber treated wounds had significantly shorter gaps in newly
formed epithelial tissue at both day 7 and day 14, exhibiting
mean epithelial gap distances of 4.4 and 1.6 mm at these time
periods (compared to 6.5 and 4.7 mm for sucrose and 7.3 and
4.5 mm for 3M™ Tegaderm™) (Fig. 4d). In addition, the suc-
cessful remodeling of the wound site following HM-PA peptide
nanofiber treatment was also associated with the rapid degra-
dation of the wound crust, which was 9.7- and 9.5-folds thinner
than the sucrose and 3M™ Tegaderm™-treated groups at day 14
(Fig. 4e). Furthermore, bioactive peptide nanofiber-treated
wounds had 16.67 ± 5.03 skin appendages per granulation area
at day 21, compared to 5.08 ± 0.82 and 10.49 ± 1.73 in sucrose
and 3M™ Tegaderm™-treated wounds, suggesting that extra-
cellular matrix remodeling was mostly complete by this time
period and that the remodeled skin was well into the process of
being repopulated by skin appendages (Fig. 4f).
Fig. 2. (A) Chemical structures of HM-PA, K-PA and E-PA. (B) Circular dichroism spectra of peptide amphiphile molecules. (C) Chemical structure of heparin. (D,E) Characterization of
peptide nanofibers at pH 7.4 by SEM. (F) General appearance of peptide scaffold gels. (G) Rheology measurements of scaffolds. Scale bars are 5 mm.
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bioactive peptide nanofiber scaffolds
Bioactive peptide nanofiber treatment was observed to greatly
enhance angiogenesis at the wound site at day 7, with a smaller
(but statistically significant compared to non-bioactive peptide
nanofiber and 3M™ Tegaderm™) increase at day 14, which is
consistent with the early induction of angiogenesis in the presence
of the bioactive peptide nanofibers (Fig. 5). However, compared to
control nanofiber and 3M™ Tegaderm™, blood vessel density was
significantly lower in HM-PA peptide nanofiber-treated wounds at
day 21, which suggests that wound recovery was complete at this
time period and that most of the blood vessels present at the
former wound site had been resorbed (Fig. 5B). The qRT-PCRFig. 3. (A) Representative images of burn wounds after gel application at days 7, 9, 12, 14,
sucrose solution, 3M™ Tegaderm™ and control nanofibers at days 7, 9, 14, and 16. Statistica
test. Error bars represent standard error of mean.analysis of VEGF and FGF-2 further supports these results, as the
considerable increase in angiogenic factor expression at day 7 was
observed to decrease at days 14 and 21 in the HM-PA peptide
nanofiber-treated group (Fig. 6). The protein-level expression of a-
SMAwas also significantly enhanced at day 7 in the HM-PA peptide
nanofiber-treated group compared to control peptide nanofiber gel
and sucrose solution, which may indicate the early differentiation
of fibroblasts into myofibroblasts in the presence of the bioactive
peptide nanofiber hydrogel. In addition to angiogenesis, the
expression of immunogenic markers IL-4, IL1-b, IL-6, MCP-1 and
TNF-a at day 7 also exhibited a downwards trend in HM-PA-treated
wounds compared to other groups; however, only the difference
between HM-PA and control nanofibers in IL-6 expression was
statistically significant (Fig. S8).16 and 21. (B) Quantification of wound areas treated with HM-PA peptide nanofibers,
l analysis was performed with one-way ANOVA and Bonferroni's multiple comparisons
Fig. 4. (A) Masson's trichrome staining of HM-PA nanofiber, sucrose solution, 3M™ Tegaderm™ and control nanofiber application at days 7, 14 and 21. Scale bars are 500 mm. (B)
Quantitative analysis of granulation tissue, (C) re-epithelization, (D) crust area, (E) wound distance and (F) skin appendages of burn wounds at days 7, 14 and 21. Statistical analysis
was performed with one-way ANOVA and Bonferroni's multiple comparisons test, *p < 0.05. Error bars represent standard error of mean.
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The ability of bioactive and non-bioactive peptide nanofiber
scaffolds and 3M™ Tegaderm™ to facilitate the deposition of well-
crosslinked collagen fibers was investigated through the picrosiriusred staining of skin sections at day 21 (Fig. 7a). In healthy skin,
picrosirius red dye stains in light/dark bands due to the presence of
non-staining hair follicles, sebaceous and sweat glands, and a
highly organized collagen structure (Fig. S9). In contrast, thewound
area is characterized by uniform staining due to the absence of skin
Fig. 5. Staining of blood vessels by anti-VWF and quantification of blood vessels at day 7, 14 and 21 (A, B). Quantification of average vessel diameter at day 7 (C). Statistical analysis
was performed with one-way ANOVA, Bonferroni's multiple comparisons test. Errors bars represent standard error of mean. Representative images were taken at 200. Scale bars
are 50 mm.
Fig. 6. Protein and mRNA levels of genes associated with angiogenesis and wound repair at the burnwound site at days 7, 14 and 21. qRT-PCR analyses were performed for VEGF and
bFGF (A, B), while Western blot analyses were performed for VEGF and alpha-SMA (C, D). Statistical analysis is performed with one-way ANOVA and Bonferroni's multiple
comparisons test. Error bars represent standard error of mean.
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restoration of the crosslinked collagen matrix is indicative of
wound recovery. Accordingly, a highly homologous picrosirius red
staining was observed in non-bioactive peptide nanofiber, 3M™
Tegaderm™ and sucrose-treated burn injuries, suggesting that
collagen crosslinking and skin appendage development are
incomplete even at day 21 for these groups. However, a heteroge-
neous pattern of staining was observed in the HM-PA peptide
nanofiber-treated wounds, which is consistent with an advanced
state of recovery and the restoration of the regular architecture of
skin. Bioactive hydrogel-treated wounds were also observed to
exhibit two distinctive alignment directions under orientation
analysis, which is similar to healthy skin and indicative of cross-
linking (Fig. 7b and c). Non-bioactive peptide nanofiber-, 3M™
Tegaderm™- and sucrose-treatedwounds, however, exhibited fiber
orientation in only a single direction, suggesting that collagen
crosslinking was not yet complete.
4. Discussion
Severe burnwounds are characterized by a strong local immune
response, higher metabolic rates at the site of injury, increased
cortisol and cytokine levels, ingress of fluid from extracellular space
to the wound site and limited transport of oxygen and nutrients,
which result in the gradual necrosis of affected tissue [8]. Conse-
quently, the effective repair of burn wounds requires the modula-
tion of metabolic, immune, homeostatic and angiogenic responses.
Heparin and heparan sulfate are glycosaminoglycans that areFig. 7. Fiber directionality resembles healthy tissue in HM-PA peptide nanofiber-treated bur
and wound areas analyzed are highlighted with dashed lines (A, B). Healthy and HM-PA p
tations, while sucrose, 3M™ Tegaderm™- and control nanofiber-treated wounds exhibit col
colour in this figure legend, the reader is referred to the web version of this article.)abundantly expressed at the burn injury site and assist in the early
wound healing process by preventing coagulation, activating a
range of pro- and anti-inflammatory pathways and binding to
growth factors such as VEGF, FGF, HGF and TGF-b that stimulate the
proliferation of fibroblasts, muscle cells, epithelial cells and endo-
thelial cells [18]. However, heparin is rapidly degraded in biological
environments and, due to its animal origin, poses a risk of zoonotic
contamination, which has stimulated the development of more
advanced delivery systems for replicating its effects on tissues [19].
Hydrogel scaffolds are especially useful for this purpose, as their
similarities to the extracellular matrix, ease of modification,
ability to constantly hydrate the site of injury and potential co-
delivery with cytokines, antibiotics, growth factors and/or stem
cells are all highly relevant properties for the treatment of burn
wounds [33].
HM-PA peptide nanofibers mimic the activity heparin and form
a biocompatible gel at neutral pH. The HM-PA peptide nanofibers
were previously shown to bind growth factors, enhance osteo-
chondrogenic differentiation, improve the success of pancreatic
islet transplantation and stimulate the repair of normal and dia-
betic wound injuries [1,13,28,36], and our present observations
suggest that the growth factor-binding, water-retaining and
glycosaminoglycan-mimicking features of HM-PA peptide nano-
fibers are also effective for stimulating the repair of full-thickness
burn injuries. In particular, HM-PA peptide nanofiber-treated
wounds had higher skin appendage formation, wound closure
and re-epithelialization rates, as well as lower granulation tissue
areas and thinner crust formation, at days 7 and 14 of the recoveryn wounds. Picrosirius red staining was performed to visualize collagen fiber orientation
eptide nanofiber-treated fibers are distributed evenly between 50 and þ50 orien-
lagen orientation only in the 50 direction (C). (For interpretation of the references to
F. Yergoz et al. / Biomaterials 134 (2017) 117e127126process, which is consistent with the prominent roles played by
heparin during early wound healing. Decreased crust formation
and lower expressions of pro-immunogenic cytokines are espe-
cially relevant to the recovery of burn wounds, which are charac-
terized by wound progression (i.e. expansion of necrotic regions,
such as the wound crust, through post-injury damage) and a
heightened inflammatory response [30]. While wound closure was
mostly complete in all groups at day 21, the bioactive peptide
nanofiber-treated group nevertheless exhibited enhanced fur
growth and a lack of scar tissue formation at later stages of re-
covery, and presented a greater amount of collagen remodeling in
Masson's trichrome staining. Consequently, HM-PA treatment was
able to support wound closure during the early repair process while
minimizing scar formation by stimulating skin appendage forma-
tion and allowing the deposition of a well-crosslinked collagen
matrix during the remodeling stage. In addition, one disadvantage
associated with peptide hydrogels is that they degrade rapidly at
the wound site, which we have counteracted here by applying each
gel thrice at days 0, 1 and 2. Gel re-application may be continued
further into the proliferation stage to obtain more pronounced re-
sults at the end of the experimental period, and individual peptide
nanofiber sequences can be tailored to each stage of recovery to
optimally enhance the entire wound repair process.
Angiogenesis is another aspect of wound healing and plays an
especially important role in burn injuries due to the anoxic and
nutrient-poor environment that characterizes these wounds [33].
However, blood vessels are typically resorbed following the
completion of the healing process, and excessive angiogenesis at
later stages of wound healing is also detrimental for the function-
ality of the repaired tissue, potentially contributing to the devel-
opment of hypertrophic scars [20]. Consequently, a balance
between angiogenic and antiangiogenic responses is necessary for
wound recovery, and the HM-PA peptide nanofibers are able to
answer this need by mediating the required transition between
blood vessel production and resorption, possibly through their
gradual degradation at the site of injury. Accordingly, the presence
of HM-PA during early wound repair is able to effectively stimulate
angiogenesis (as shown by vonWillebrand factor staining at days 7
and 14, as well as VEGF expression analysis at day 7), while its
degradation during the following days would allow the remodeling
step to proceed. As HM-PA peptide nanofibers have previously been
shown to specifically interact with VEGF165 through its heparin-
binding domain [13], it is likely that the promotion of angiogen-
esis occurs through the retention of endogenously produced VEGF,
enhancement of its presentation, and/or stimulation of autocrine
signaling from the cells at the site of injury, all of which are known
roles of heparin. Promotion of cellular recruitment and differenti-
ation is another possible mechanism behind enhanced angiogen-
esis and VEGF production, as heparin and its binding factors (such
as EGF) have been reported to induce fibroblast recruitment, pro-
liferation and differentiation [4,5,9,14,27].
Following injury, the collagen matrix at the wound site is
completely denatured, leaving a disordered and necrosis-
promoting extracellular environment. During the wound repair
process, the cellular debris at the wound site is removed by in-
flammatory cells, and a new, well-crosslinked collagen matrix is
deposited by local and recruited fibroblasts. Collagen alignment can
therefore be used as a measure of the wound healing progress, as
healthy extracellular matrix is characterized by two axes of
collagen fibers that intersect to create a basket-woven appearance,
while the old, dysfunctional extracellular matrix exhibits only a
single collagen axis [2]. In sucrose and 3M™ Tegaderm™-treated
wounds, orientation analysis showed that collagen fibers were ar-
ranged in only a single axis, while healthy and HM-PA peptide
nanofiber-treated tissues were characterized by the deposition ofcollagen in two axes of orientation. This enhancement of collagen
crosslinking was also supported by the early expression of a-SMA,
which is responsible for fibroblast activation, wound contraction
and extracellular matrix remodeling. In addition, sucrose- and
3M™ Tegaderm™-treated samples exhibited some “gaps” without
picrosirius red staining, suggesting that collagen deposition was
incomplete in these samples, while the entire dermal layer was
stained extensively with picrosirius red for healthy and HM-PA
peptide nanofiber-treated samples. The ability of HM-PA to
induce the deposition of awell-crosslinked collagenmatrix appears
to be an indirect consequence of its regeneration-promoting effects
during earlier stages of recovery, as the material is subject to
biodegradation and would be present only in minute quantities at
the end of the 21-day experimental period.
5. Conclusions
In summary, we demonstrated that the heparin-mimetic pep-
tide nanofibers are able to support the repair of full-thickness burn
injuries by mediating wound contraction and re-epithelialization,
preventing scar formation, and stimulating the development of
skin appendages. In addition, enhanced wound recovery in the
heparin-mimetic peptide nanofiber-treated group was found to be
associated with the induction of neovascularization and the
deposition of an extensively crosslinked collagen matrix. It is
especially notable that the commercial wound filling 3M™ Tega-
derm™was significantly less effective inmany of these aspects. The
burn injury and treatment model used in the present study closely
resembles the standard of care for burn wounds, which entails the
removal of necrotic tissue and the implantation of autografts and/or
collagen-based scaffolds. However, the wounds were subcritical
and accounted for c. 1.5% of the total body skin area of mice. In
addition, human skin is associated with a sparsity of hair follicles,
increased epidermal thickness and differences in immune cell
populations compared to murine skin, which should be considered
for the applicability of the HM-PA hydrogel to severe burns in hu-
man patients. Nevertheless, we suggest that the HM-PA peptide
nanofiber system is suitable for adaptation to clinical settings for
minor to moderate burn injuries that do not necessitate autograft
treatment.
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